Search results for "Coco"

showing 10 items of 402 documents

Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus.

2010

BACKGROUND: One of the major goals of pemphigus therapy is to reduce the patient's cumulative exposure to systemic corticosteroids. To investigate the efficacy of enteric-coated mycophenolate sodium (EC-MPS), 10 patients with active, refractory pemphigus vulgaris (PV) or foliaceous (PF) were treated with EC-MPS (1440 mg daily) and prednisone (75 mg daily) over 18 months. OBSERVATIONS: Following EC-MPS/prednisone therapy, disease progression was inhibited between days 30 and 45 in 9/10 patients (8 PV; 1 PF). At 18 months, 8/9 PV patients had clinically quiescent disease; EC-MPS therapy was no longer required in two patients as a result of disease remission. The remaining PV patient showed no…

AdultMaleAdministration OralMiddle AgedMycophenolic AcidTreatment OutcomeSettore MED/35 - Malattie Cutanee E VenereeEnteric-coated Mycophenolate SodiumHumansPrednisoneDrug Therapy CombinationFemaleTablets Enteric-CoatedGlucocorticoidsImmunosuppressive AgentsPemphigusFollow-Up StudiesInternational journal of dermatology
researchProduct

Risk factors for classical Kaposi's sarcoma.

2002

Background: Classical Kaposi's sarcoma (KS) is a malignancy of lymphatic endothelial skin cells. Although all forms of KS are associated with the KS-associated herpesvirus (KSHV), classical KS occurs in a small fraction of KSHV-infected people. We sought to identify risk factors for classical KS in KSHV-infected individuals. Methods: Lifestyle and medical history data from case patients with biopsyproven non-AIDS (non-acquired immunodeficiency syndrome) KS in Italy were compared by logistic regression analysis with data from population-based KSHV-seropositive control subjects of comparable age and sex. After KSHV immunofluorescence testing, randomly selected patients on the rosters of local…

AdultMaleCancer Researchmedicine.medical_specialtyAdolescentAdministration TopicalPopulationAnti-Inflammatory AgentsAntibodies ViralRisk FactorsInternal medicineEpidemiologymedicineConfidence IntervalsOdds RatioHumansMedical historyRisk factoreducationMedical History TakingKaposi's sarcomaGlucocorticoidsLife StyleSarcoma KaposiAsthmaAgedAged 80 and overeducation.field_of_studybusiness.industrySmokingHygieneOdds ratioHerpesviridae InfectionsMiddle Agedmedicine.diseaseConfidence intervalAsthmaOncologyItalyCase-Control StudiesImmunologyHerpesvirus 8 HumanMultivariate AnalysisFemalebusinessJournal of the National Cancer Institute
researchProduct

Efficacy of mometasone furoate microemulsion in the treatment of erosive-ulcerative oral lichen planus: pilot study

2004

Background:  Oral lichen planus (OLP) is a frequent immunological chronic disease, having different clinical forms: asymptomatic and symptomatic. Symptomatic OLP has been palliated with topical corticosteroids with different levels of efficacy and safety. The purpose of this pilot phase II clinical trial was to determine the efficacy of mometasone furoate microemulsion upon the symptoms and signs of erosive-ulcerative OLP. Methods:  Forty-nine patients with clinical and histologically confirmed erosive-ulcerative OLP were enrolled in this study (36 women and 13 men). Their average age was 56.4 years (from 28 to 78). The treatment consisted of 0.1% mometasone furoate microemulsion mouthwash …

AdultMaleCancer Researchmedicine.medical_specialtyErythemamedicine.drug_classAdministration TopicalAnti-Inflammatory AgentsMouthwashesMometasone furoatePilot ProjectsAsymptomaticPathology and Forensic Medicinestomatognathic systemHumansMedicineAdverse effectGlucocorticoidsPregnadienediolsAgedbusiness.industryMometasoneMiddle Agedmedicine.diseaseDermatologyClinical trialstomatognathic diseasesOtorhinolaryngologyPeriodonticsCorticosteroidEmulsionsFemaleOral lichen planusOral Surgerymedicine.symptombusinessMometasone FuroateLichen Planus Oralmedicine.drugJournal of Oral Pathology and Medicine
researchProduct

Randomized trial of intravenous immunoglobulins versus prednisolone in Graves' ophthalmopathy.

1996

Abstract Glucocorticoids are usually given for management of Graves' ophthalmopathy (GO), but they may cause side effects. By comparison, intravenous administration of immunoglobulins resulted in clinical improvement and decreased antibody titres in a large number of autoimmune diseases. Therefore, a randomized trial was done, in which 19 patients with active GO were treated with a 20-week course of oral prednisolone (P, starting dose 100 mg/day), and 21 received 1 g immunoglobulin/kg body weight for 2 consecutive days every 3 weeks. The immunoglobulin course was repeated six times. Before and at the end (20 weeks) of immunomodulating therapy, ophthalmological investigation and quantitative…

AdultMaleIntraocular pressureThyroid HormonesVisual acuityEye DiseasesGraves' diseasePrednisoloneImmunologyAdministration OralThyroglobulinlaw.inventionGraves' ophthalmopathyRandomized controlled triallawOral administrationmedicineImmunology and AllergyHumansProspective StudiesGlucocorticoidsAutoantibodiesbusiness.industryImmunoglobulins IntravenousReceptors ThyrotropinOriginal ArticlesMiddle Agedmedicine.diseaseMagnetic Resonance ImagingAnti-thyroid autoantibodiesGraves DiseaseImmunologyPrednisoloneFemalemedicine.symptombusinessmedicine.drugClinical and experimental immunology
researchProduct

Long-term observation of endocrine ophthalmopathy and retrospective appraisal of therapeutic measures.

1990

The course of endocrine ophthalmopathy was investigated on the basis of clinical and biochemical parameters and in relation to different therapeutic strategies. A retrospective appraisal was made of 297 patients (44 +/- 14 yr, 249 women) with inclusion of anamnestic and clinical data as well as the results of computer tomography. At the beginning of therapy, 253 patients were hyperthyroid, 36 were euthyroid and eight were hypothyroid. The HLA typing carried out in 89 patients showed the phenotypes B8 and DR3 in 32% and 42% of the cases, respectively. Raised microsomal antibodies were present in 56% of the patients and there were raised thyroglobulin antibodies in 19%. Sixty-three % of the p…

AdultMaleIntraocular pressuremedicine.medical_specialtyTime FactorsAdolescentEye DiseasesEndocrinology Diabetes and MetabolismEye diseasemedicine.medical_treatmentVision DisordersCyclosporinsEndocrine System DiseasesEyeAutoimmune DiseasesEndocrinologyImmunopathologyInternal medicinemedicineExophthalmosHumansEuthyroidEndocrine ophthalmopathyGlucocorticoidsIntraocular PressureVision OcularAgedRetrospective Studiesbusiness.industryMusclesRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryPrednisoneThyroglobulinFemalebusinessComplicationTomography X-Ray ComputedJournal of endocrinological investigation
researchProduct

Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.

2006

Many women with 21-hydroxylase (21-OH)-deficient nonclassic adrenal hyperplasia (NCAH) carry at least one allele containing a severe mutation of CYP21, and as such are at risk for giving birth to an infant having classic adrenal hyperplasia (CAH). Infants with NCAH typically are asymptomatic at birth, in contrast to those with CAH, but they do develop symptoms of hyperandrogenism later in childhood or as adults. This international multicenter study, conducted both retrospectively and prospectively, was an attempt to determine how often mothers with 21-OH-deficient NCAH bear infants having CAH or NCAH. The 101 women entering the study had a total of 203 pregnancies that could be evaluated. F…

AdultMalePediatricsmedicine.medical_specialtyReferralGenotypeOffspringEndocrinology Diabetes and MetabolismClinical BiochemistryContext (language use)AsymptomaticBiochemistryEndocrinologyPregnancyInternal medicinePrevalenceMedicineHumansProspective StudiesProspective cohort studyAdrenal HyperplasiaRetrospective StudiesPregnancybiologyAdrenal Hyperplasia Congenitalbusiness.industryIncidence (epidemiology)HyperandrogenismBiochemistry (medical)21-HydroxylaseInfant NewbornObstetrics and GynecologyInfantRetrospective cohort studyGeneral MedicineHyperplasiamedicine.diseaseEndocrinologyGlucocorticoid therapyChild Preschoolbiology.proteinFemaleSteroid 21-Hydroxylasemedicine.symptomLive birthbusinessThe Journal of clinical endocrinology and metabolism
researchProduct

Budesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmatics

2015

Abstract Background Reduced innate immunity responses as well as reduced T regulatory activities characterise bronchial asthma. Objectives In this study the effect of budesonide on the expression of TLR4 and TLR2 in T regulatory lymphocyte sub-population was assessed. Methods TLR4 and TLR2 expression in total peripheral blood mononuclear cells (PBMC), in CD4+/CD25+ and in CD4+/CD25− was evaluated, by flow cytometric analysis, in mild intermittent asthmatics (n = 14) and in controls (n = 11). The in vitro effects of budesonide in modulating: TLR4 and TLR2 expression in controls and in asthmatics; IL-10 expression and cytokine release (IL-6 and TNF-α selected by a multiplex assay) in asthmati…

AdultMalePulmonary and Respiratory MedicineBudesonidemedicine.medical_treatmentLymphocyteIn Vitro TechniquesCorticosteroids; Immunoregulation; T lymphocytes; TLR; Adult; Asthma; Budesonide; Cytokines; Female; Flow Cytometry; Glucocorticoids; Humans; In Vitro Techniques; Interleukin-10; Leukocytes Mononuclear; Male; T-Lymphocytes Regulatory; Toll-Like Receptor 2; Toll-Like Receptor 4; Young Adult; Pulmonary and Respiratory Medicine; Pharmacology (medical); Biochemistry (medical); Medicine (all)T-Lymphocytes RegulatoryPeripheral blood mononuclear cellYoung AdultGlucocorticoidTLRT lymphocytemedicineCorticosteroidHumansPharmacology (medical)IL-2 receptorBudesonideCytokineGlucocorticoidsIn Vitro Techniquebusiness.industryMedicine (all)Biochemistry (medical)ImmunoregulationFlow CytometryAsthmaToll-Like Receptor 2Interleukin-10Toll-Like Receptor 4Interleukin 10TLR2Cytokinemedicine.anatomical_structureImmunologyLeukocytes MononuclearTLR4CytokinesFemalebusinessHumanmedicine.drugPulmonary Pharmacology & Therapeutics
researchProduct

Impact of antenatal glucocorticoid therapy and risk of preterm delivery on intelligence in term-born children

2015

Context: Women at risk of preterm delivery are routinely treated with synthetic glucocorticoids (sGCs). Although this therapy substantially reduces neonatal morbidity, concerns remain whether sGC excess may disrupt neurodevelopmental trajectories underlying cognitive functioning. Objective: The present study is the first to disentangle direct effects of antenatal sGC treatment on possible long-term cognitive disadvantages from those of pregnancy complications and prematurity. Design, Setting, and Participants: This cross-sectional study included a mixed-sex cohort of 222 term-born children (aged 6–11 years) consisting of three groups: children of mothers admitted to hospital for threatening…

AdultMaleRisk0301 basic medicinemedicine.medical_specialtyPediatricsTerm BirthCross-sectional studyEndocrinology Diabetes and MetabolismIntelligenceClinical BiochemistryContext (language use)Prenatal careBetamethasoneBiochemistryDexamethasoneCohort Studies03 medical and health sciencesCognitionObstetric Labor Premature0302 clinical medicineEndocrinologyPregnancyHumansMedicineChildGlucocorticoidsIntelligence TestsPregnancybusiness.industryObstetricsBiochemistry (medical)medicine.diseasePregnancy ComplicationsSexual Dysfunction PhysiologicalCross-Sectional Studies030104 developmental biologyPremature birthPrenatal Exposure Delayed EffectsCohortddc:618.97BetamethasoneFemalebusiness030217 neurology & neurosurgerymedicine.drugCohort study
researchProduct

A rare case of abdominal cocoon.

2013

Abdominal cocoon is a rare cause of intestinal obstruction usually diagnosed incidentally at laparotomy. It manifests by forming a membrane that typically encases the small bowel loops, leading to mechanical obstruction. Preoperative diagnosis is difficult. The etiology of this condition is not well understood; however, it is a form of chronic irritation and inflammation.A 33 years old male, from Bangladesh, presented to our emergency department complaining of abdominal pain, nausea, and vomiting. CT abdomen shows a picture of intestinal obstruction at the level of the small intestine. Intraoperative findings showed encapsulation of small bowel by a dense whitish membrane as a cocoon. Histo…

AdultMaleSettore MED/18 - Chirurgia GeneraleAscariasisLaparotomyIleal DiseasesAnimalsHumansAscaris Lumbricoides Cocoon syndrome Intestinal obstruction Granulomatous peritonitisPeritonitisAscaris lumbricoidesIntestinal ObstructionAnnali italiani di chirurgia
researchProduct

The effect of an 1100 km run on testicular, adrenal and thyroid hormones

1984

Although endocrine effects of physical or psychological stress are well documented, it is not known to what extent adaptation to prolonged exertion occurs. We therefore investigated the impact of an 1100 km run of 20 days' duration on selected pituitary, testicular, adrenal and thyroid hormones. Blood samples were obtained from five male athletes prior to and after the day's run on the 1st, 5th, 9th, 14th and 19th day. Results show that adrenal and thyroid function soon adapt to the daily strain. Testosterone levels, however, were markedly decreased throughout the 20 days while LH levels remained unchanged. Thus it appears that the reproductive endocrine system is more susceptible to long-t…

AdultMaleThyroid Hormonesmedicine.medical_specialtyHydrocortisoneUrologyEndocrinology Diabetes and MetabolismPhysical ExertionRunningchemistry.chemical_compoundDehydroepiandrosterone sulfateAdrenal Cortex HormonesStress PhysiologicalInternal medicinemedicineHumansEndocrine systemTestosteroneTesticular HormonesTestosteroneHydrocortisoneDehydroepiandrosterone Sulfatebusiness.industryThyroidDehydroepiandrosteroneLuteinizing HormoneProlactinTesticular HormonesThyroxineEndocrinologymedicine.anatomical_structureReproductive MedicinechemistryThyroid functionbusinessGlucocorticoidmedicine.drugInternational Journal of Andrology
researchProduct